Human Recombinant I-TAC (from E. coli)
1 mg, US
Catalog # 10780-544
Supplier: Peprotech
Supplier #: 300-46-1MG
Jump to:
- Item requires temperature control for storage and delivery with additional fees. It's not eligible for return due to safety and quality concerns. Consider requirements before purchasing.
- Return Policy
Product Details & Documents
I-TAC is a 'non-ELR' CXC chemokine that is regulated by interferon and signals through the CXCR3 receptor. I-TAC is chemoattractant for IL-2 activated T cells, but does not affect freshly isolated un-stimulated T cells, neutrophils, or monocytes. Recombinant Human I-TAC (CXCL11) is an 8.3 kDa protein containing 73 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines.
Ordering information: For research use only. Not for use in diagnostic or therapeutic procedures.
Specifications
Specifications
- Size:1 mg
- Origin:US
- Protease-free:Y
- Form:Lyophilized
- Protein/peptide name:I-TAC
- Protein synonyms:Interferon Inducible T-Cell α Chemokine|B-R1
- Protein Function:Cytokines and Growth Factors
- Purity:0.98
- Endotoxin level:Low
- Sequence:FPMFKRGRCL CIGPGVKAVK VADIEKASIM YPSNNCDKIE VIITLKENKG QRCLNPKSKQ ARLIIKKVER KNF
- Source:E. coli
- Biological activity:Biological Activity tests can vary. Please refer to the Product CoA for information.
- Molecular weight:8.3 kDa
- Shipping temperature:Ambient
- Cat. No.:10780-544
- Reconstitution instructions:Reconstitution instructions can vary. Please refer to the product CoA for info.
- Protein/peptide type:Recombinant
- Endotoxin content:>0.1 ng/μg
- Storage conditions:Store at –20 °C prior to reconstitution.
- Gene ID:6373 O14625
- Formulation:Formulation can vary. Please refer to product CoA for information.
- Conjugation:Unconjugated
- Species:Human
Specifications
Recommendations
Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".
Otherwise, you will receive generic recommendations.



